$TBRG
TruBridge Inc Stock $tbrg

$tbrg Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000116944524000017 Filed on March 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$83.25M	$85.87M	$339.4M
YoY Change	-3.46%	3.18%	3.91%
Cost Of Revenue	$41.76M	$43.70M	$175.9M
YoY Change	-5.47%	-5.16%	2.12%
Gross Profit	$41.49M	$42.17M	$163.6M
YoY Change	-1.35%	13.51%	5.91%
Gross Profit Margin	49.84%	49.11%	48.19%
Selling, General & Admin	$25.99M	$27.83M	$104.2M
YoY Change	18.61%	33.07%	25.06%
% of Gross Profit	62.64%	65.98%	63.71%
Research & Development	$10.69M	$10.35M	$37.25M
YoY Change	8.67%	16.39%	20.44%
% of Gross Profit	25.76%	24.53%	22.77%
Depreciation & Amortization	$400.0K	$7.528M	$1.946M
YoY Change	-19.68%	20.64%	-20.34%
% of Gross Profit	0.96%	17.85%	1.19%
Operating Expenses	$36.68M	$45.70M	$141.4M
YoY Change	2.56%	33.29%	7.44%
Operating Profit	-$1.458M	-$3.526M	-$42.60M
YoY Change	-123.16%	-223.03%	-287.0%
Interest Expense	$4.072M	-$4.116M	$12.52M
YoY Change	52.57%	80.84%	98.12%
% of Operating Profit
Other Income/Expense, Net	-$2.650M	$176.0K	-$11.78M
YoY Change	10.32%	-33.33%	150.45%
Pretax Income	-$4.108M	-$45.72M	-$54.38M
YoY Change	-205.52%	-2602.52%	-400.76%
Income Tax	-$1.592M	-$3.247M	-$8.591M
% Of Pretax Income
Net Earnings	-$2.516M	-$41.52M	-$45.79M
YoY Change	-181.58%	-1782.89%	-388.58%
Net Earnings / Revenue	-3.02%	-48.35%	-13.49%
Basic Earnings Per Share	-$0.17		-$3.15
Diluted Earnings Per Share	-$0.17	-$2.92	-$3.15
COMMON SHARES
Basic Shares Outstanding	14.51M shares	14.55M shares	14.19M shares
Diluted Shares Outstanding	14.23M shares		14.19M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.115M	$3.848M	$3.848M
YoY Change	-39.63%	-44.64%	-44.64%
Cash & Equivalents	$4.115M	$3.848M	$3.848M
Short-Term Investments
Other Short-Term Assets	$18.92M	$43.41M	$43.41M
YoY Change	24.93%	293.26%	293.26%
Inventory	$980.0K	$475.0K	$475.0K
Prepaid Expenses
Receivables	$64.22M	$59.72M	$59.72M
Other Receivables	$3.668M	$3.997M	$3.997M
Total Short-Term Assets	$91.90M	$111.5M	$111.5M
YoY Change	11.67%	49.49%	49.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.750M	$8.974M	$14.17M
YoY Change	-6.93%	-9.21%	-18.82%
Goodwill	$172.6M	$171.9M
YoY Change	-12.95%	-13.29%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.331M	$7.314M	$7.314M
YoY Change	19.48%	-10.05%	-10.05%
Total Long-Term Assets	$324.5M	$323.0M	$323.0M
YoY Change	-8.47%	-9.38%	-9.38%
TOTAL ASSETS
Total Short-Term Assets	$91.90M	$111.5M	$111.5M
Total Long-Term Assets	$324.5M	$323.0M	$323.0M
Total Assets	$416.4M	$434.4M	$434.4M
YoY Change	-4.68%	0.8%	0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.36M	$10.13M	$10.13M
YoY Change	-10.16%	44.04%	44.04%
Accrued Expenses	$22.61M	$24.26M	$24.26M
YoY Change	4.05%	6.92%	6.92%
Deferred Revenue	$9.079M	$8.677M
YoY Change		-25.13%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.074M	$3.141M	$3.141M
YoY Change	-2.13%	0.0%	0.0%
Total Short-Term Liabilities	$47.16M	$48.23M	$48.23M
YoY Change	-4.04%	8.49%	8.49%
LONG-TERM LIABILITIES
Long-Term Debt	$181.7M	$195.3M	$195.3M
YoY Change	34.02%	43.17%	43.17%
Other Long-Term Liabilities	$2.848M	$3.074M	$3.074M
YoY Change	-45.3%	-45.6%	-45.6%
Total Long-Term Liabilities	$181.7M	$195.3M	$198.3M
YoY Change	34.02%	43.17%	39.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.16M	$48.23M	$48.23M
Total Long-Term Liabilities	$181.7M	$195.3M	$198.3M
Total Liabilities	$231.7M	$247.8M	$247.8M
YoY Change	14.0%	24.37%	24.37%
SHAREHOLDERS EQUITY
Retained Earnings	$5.616M	$8.132M
YoY Change	-90.15%	-84.92%
Common Stock	$196.4M	$195.6M
YoY Change	1.46%	1.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$184.7M	$186.6M	$186.6M
YoY Change
Total Liabilities & Shareholders Equity	$416.4M	$434.4M	$434.4M
YoY Change	-4.68%	0.8%	0.8%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.516M	-$41.52M	-$45.79M
YoY Change	-181.58%	-1782.89%	-388.58%
Depreciation, Depletion And Amortization	$400.0K	$7.528M	$1.946M
YoY Change	-19.68%	20.64%	-20.34%
Cash From Operating Activities	-$2.034M	-$12.26M	$1.059M
YoY Change	-121.47%	-666.59%	-96.73%
INVESTING ACTIVITIES
Capital Expenditures	$177.0K	$5.095M	$346.0K
YoY Change	1006.25%	9.83%	28.15%
Acquisitions			$36.71M
YoY Change			-15.36%
Other Investing Activities	$21.41M	-$36.71M	-$36.71M
YoY Change		-11155.72%	-15.36%
Cash From Investing Activities	$16.39M	-$41.80M	-$60.11M
YoY Change	-362.35%	870.51%	-4.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.575M
YoY Change			-78.4%
Debt Paid & Issued, Net	$875.0K		$3.500M
YoY Change	0.0%		-1.77%
Cash From Financing Activities	-$14.05M	56.43M	$55.95M
YoY Change	318.34%	-972.96%	116.22%
NET CHANGE
Cash From Operating Activities	-$2.034M	-12.26M	$1.059M
Cash From Investing Activities	$16.39M	-41.80M	-$60.11M
Cash From Financing Activities	-$14.05M	56.43M	$55.95M
Net Change In Cash	$308.0K	2.367M	-$3.103M
YoY Change	-328.15%	-127.5%	-30.74%
FREE CASH FLOW
Cash From Operating Activities	-$2.034M	-$12.26M	$1.059M
Capital Expenditures	$177.0K	$5.095M	$346.0K
Free Cash Flow	-$2.211M	-$17.36M	$713.0K
YoY Change	-123.38%	601.25%	-97.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	54 St. Emanuel Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Mobile
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	36602
CY2023	dei	City Area Code CityAreaCode	251
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3631000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59723000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37246000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	27131000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48481000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8591000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2214000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15867000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	18430000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	43364000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60110000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62731000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4646000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5300000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	35000000	usd
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001169445
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity File Number EntityFileNumber	000-49796
CY2023	dei	Entity Registrant Name EntityRegistrantName	TruBridge, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-3032373
CY2023	dei	Local Phone Number LocalPhoneNumber	639-8100
CY2023	dei	Trading Symbol TradingSymbol	TBRG
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	358665532	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14507776	shares
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3848000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6951000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2854000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51311000	usd
CY2023Q4	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	319000	usd
CY2022Q4	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	223000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3997000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	4474000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	475000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	784000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1628000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	701000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15807000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10338000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	25977000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	111455000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	74559000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8974000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9884000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	39139000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	27257000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5192000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7567000	usd
CY2023Q4	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	97000	usd
CY2022Q4	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	326000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1226000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3312000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7314000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8131000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89213000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	102000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	171909000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	198253000	usd
CY2023Q4	us-gaap	Assets Assets	434422000	usd
CY2022Q4	us-gaap	Assets Assets	430963000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10133000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7035000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3141000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3141000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8677000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11590000	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	5410000	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	6214000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	19892000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16475000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	977000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48230000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44455000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	195270000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	136388000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3074000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5651000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1230000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12758000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	247804000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	199252000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15121000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15121000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14913000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14913000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	15000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	195546000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	192275000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8132000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	53921000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	572000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	483000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	17075000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	14500000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	186618000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	231711000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	434422000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	430963000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	339435000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	326648000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	280629000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	175868000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	166541000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	135781000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31898000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32809000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21978000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35913000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2342000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	382039000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	303865000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	255922000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-42604000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	22783000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	24707000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	745000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1178000	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1529000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-565000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-125000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	12521000	usd
CY2022	us-gaap	Interest Expense InterestExpense	6320000	usd
CY2021	us-gaap	Interest Expense InterestExpense	3160000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11776000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4702000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1631000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54380000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18081000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23076000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45789000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	200000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	18430000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5457000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1315000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5173000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	11924000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	231711000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45789000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3271000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2575000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	186618000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45789000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15867000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	18430000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1920000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	992000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2592000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11305000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6688000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3502000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3271000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5173000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5457000	usd
CY2023	us-gaap	Depreciation Depreciation	1946000	usd
CY2022	us-gaap	Depreciation Depreciation	2443000	usd
CY2021	us-gaap	Depreciation Depreciation	2156000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16426000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17403000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13786000	usd
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	8096000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	3484000	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	931000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	359000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	332000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	293000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-565000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35913000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2342000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-125000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-117000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-313000	usd
CY2023	cpsi	Operating Lease Cost Non Cash OperatingLeaseCostNonCash	1602000	usd
CY2022	cpsi	Operating Lease Cost Non Cash OperatingLeaseCostNonCash	2166000	usd
CY2021	cpsi	Operating Lease Cost Non Cash OperatingLeaseCostNonCash	1753000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11319000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12428000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3204000	usd
CY2023	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-2659000	usd
CY2022	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-6144000	usd
CY2021	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-8098000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-309000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-71000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-229000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4554000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2930000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3914000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3075000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1429000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-615000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2913000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	61000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2099000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2063000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2019000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1753000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1894000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	275000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	401000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-927000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3898000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2810000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1059000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32375000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47744000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	346000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	270000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	920000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	36705000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	59634000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	23059000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	19097000	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9365000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69919000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	575000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3500000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3563000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3750000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	67023000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	48000000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	61000000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5000000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1935000	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2575000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11924000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1315000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55948000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25876000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20935000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3103000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4480000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1240000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6951000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11431000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12671000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3848000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6951000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11431000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	9298000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5863000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2817000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3659000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4765000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3503000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	NATURE OF OPERATIONS<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Founded in 1979, TruBridge, Inc. (“TruBridge” or the “Company”) is a leading provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. Previously named Computer Programs and Systems, Inc., the Company changed its name to TruBridge, Inc. on March 4, 2024 in a Company-wide rebranding and legal entity consolidation. During 2023, TruBridge was the parent of ten companies – Evident, LLC (“Evident”), Healthland Holding Inc. (“HHI”), Healthland Inc., Rycan Technologies, Inc., American HealthTech, Inc. (“AHT”), TruBridge, LLC, iNetXperts, Corp d/b/a Get Real Health (“GRH”), TruCode LLC (“TruCode”), Healthcare Resource Group, Inc. (“HRG”) and Viewgol, LLC (“Viewgol”). Our combined companies are focused on helping improve the health of the communities we serve, connecting communities for a better patient care experience, and improving the financial operations of our customers. </span></div><div style="margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates its business in three operating segments, which are also our reportable segments: RCM, EHR, and Patient Engagement. These reporting segments contribute towards the combined focus of improving the health of the communities we serve as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Revenue Cycle Management (“RCM”) reporting segment focuses on providing a complete RCM solution for all care settings, regardless of their primary healthcare information solutions provider along with business management, consulting, managed IT services, analytics and business intelligence. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">The </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic health record (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EHR”) segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. AHT is one of the nation’s largest providers of post-acute care EHR solutions and services for post-acute care facilities. In January 2024, the Company disposed of its interest in AHT, refer to Note 19 – Subsequent Events for more information. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Patient Engagement segment offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers.</span></div>
CY2023Q4	cpsi	Number Of Subsidiaries NumberOfSubsidiaries	10	subsidiary
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Presentation</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the fourth quarter of 2022, the Company realigned its reporting structure due to certain organizational changes. As a result, the Company changed its three reportable segments from (i) TruBridge, (ii) Acute Care EHR, and (iii) Post-acute care EHR to (i) RCM, (ii) EHR, and (iii) Patient Engagement. All prior segment information has been recast to reflect the Company's new segment structure and current period presentation. Refer to Note 18 - Segment Reporting for more information.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional changes to the presentation of amounts within our condensed consolidated statements of income are as follows:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the first quarter of 2023, we identified certain costs related to the implementation of our cloud strategy and our security operations center that were recorded within the caption "Costs of revenue (exclusive of amortization and depreciation) - EHR" on our condensed consolidated statements of operations, that we determined do not solely contribute to the production of EHR products and services, but support the overall business. Consequently, effective January 1, 2023, certain costs related to the implementation of our cloud strategy, which were formerly included within the caption "Costs of revenue (exclusive of amortization and depreciation) - EHR," have been recorded as components of "Product development" expenses. In addition, certain costs related to the Company's security operations center, which were formerly included within the caption "Costs of revenue (exclusive of amortization and depreciation) - EHR," have been recorded as components of "General and administrative" expenses. Additionally, immaterial travel costs were reclassified from within the caption "Costs of revenue (exclusive of amortization and depreciation) - RCM" to "Product development" expenses. Amounts presented for the years ended December 31, 2022 and 2021 have been reclassified to conform to the current presentation. </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In addition, during the first quarter of 2023, we refined our operating expense allocation methodology to more accurately distribute the appropriate share of costs among operating segments. Amounts presented for the years ended December 31, 2022 and 2021 have been reclassified and are reflective of the current operating expense methodology in order to conform to the current presentation. </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the third quarter of 2023, we changed the presentation of certain costs previously recorded within the expense captions of "Product development" and "General and administrative" to better comply with the disclosure requirements of Staff Accounting Bulletin Topic 11.B., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Miscellaneous Disclosure: Depreciation and Depletion Excluded from Cost of Sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These changes are summarized as follows:</span></div><div style="margin-top:9pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">◦</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Amortization expense associated with capitalized software development costs, previously recorded within the expense caption of "Product development," has been combined with amounts previously recorded within the expense caption "Amortization of acquisition-related intangibles" and reflected in a newly-presented expense caption of "Amortization."</span></div><div style="margin-top:9pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">◦</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Depreciation expense previously recorded within the expense caption of "General and administrative" has been reclassified within the newly-presented expense caption of "Depreciation."</span></div><div style="margin-top:9pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">◦</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The expense caption previously labelled as "Costs of sales" has been renamed "Costs of revenue (exclusive of amortization and depreciation)," with the previously reported reference to "Gross profit" removed from the current presentation.</span></div>
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31898000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54965000	usd
CY2022	cpsi	Amortization Of Acquisition Related Intangibles AmortizationOfAcquisitionRelatedIntangibles	0	usd
CY2022	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	20887000	usd
CY2022	us-gaap	Depreciation Depreciation	2443000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32809000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48481000	usd
CY2021	cpsi	Amortization Of Acquisition Related Intangibles AmortizationOfAcquisitionRelatedIntangibles	0	usd
CY2021	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	14717000	usd
CY2021	us-gaap	Depreciation Depreciation	2156000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11590000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11529000	usd
CY2023	cpsi	Contract With Customer Liability Period Increase Decrease ContractWithCustomerLiabilityPeriodIncreaseDecrease	17192000	usd
CY2022	cpsi	Contract With Customer Liability Period Increase Decrease ContractWithCustomerLiabilityPeriodIncreaseDecrease	25579000	usd
CY2023	cpsi	Contract With Customer Liability Including New Contract Revenue Recognized ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized	20105000	usd
CY2022	cpsi	Contract With Customer Liability Including New Contract Revenue Recognized ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized	25518000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8677000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11590000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	11577000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	7312000	usd
CY2023	cpsi	Costs To Obtain And Fulfill Contracts Capitalized CostsToObtainAndFulfillContractsCapitalized	7390000	usd
CY2022	cpsi	Costs To Obtain And Fulfill Contracts Capitalized CostsToObtainAndFulfillContractsCapitalized	11361000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-5852000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-7096000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	13115000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	11577000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22668000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21205000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13694000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11321000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8974000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9884000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	51349000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	31789000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	12210000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	4532000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	39139000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	27257000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14187000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14356000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14290000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	5194000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8430000	usd
CY2023Q4	cpsi	Accrued Severance Current AccruedSeveranceCurrent	5806000	usd
CY2022Q4	cpsi	Accrued Severance Current AccruedSeveranceCurrent	2504000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1185000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1280000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1358000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1044000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4859000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	840000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1804000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2063000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	19892000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16475000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45789000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15867000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	18430000	usd
CY2023	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	-1030000	usd
CY2022	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	311000	usd
CY2021	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	409000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44759000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15556000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18021000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14187000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14356000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14290000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.15
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-44759000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	15556000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	18021000	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	28000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14187000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14356000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14318000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.15
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2023Q4	cpsi	Deferred Tax Assets Accounts Receivableand Financing Receivables DeferredTaxAssetsAccountsReceivableandFinancingReceivables	871000	usd
CY2022Q4	cpsi	Deferred Tax Assets Accounts Receivableand Financing Receivables DeferredTaxAssetsAccountsReceivableandFinancingReceivables	877000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1275000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1909000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	367000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1002000	usd
CY2023Q4	cpsi	Deferred Tax Assets Tax Deferred Expense Research Expenditures DeferredTaxAssetsTaxDeferredExpenseResearchExpenditures	16496000	usd
CY2022Q4	cpsi	Deferred Tax Assets Tax Deferred Expense Research Expenditures DeferredTaxAssetsTaxDeferredExpenseResearchExpenditures	9779000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	890000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	490000	usd
CY2023Q4	cpsi	Deferred Tax Assets Right Of Use Asset DeferredTaxAssetsRightOfUseAsset	952000	usd
CY2022Q4	cpsi	Deferred Tax Assets Right Of Use Asset DeferredTaxAssetsRightOfUseAsset	1848000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2770000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	814000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3656000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3738000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27277000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20457000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	604000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	604000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26673000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	19853000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	14477000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	20941000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	12127000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	9259000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	254000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	254000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	527000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	527000	usd
CY2023Q4	cpsi	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1045000	usd
CY2022Q4	cpsi	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1884000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	27903000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	32611000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1230000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12758000	usd
CY2022Q4	cpsi	Deferred Tax Assets Tax Deferred Expense Research Expenditures DeferredTaxAssetsTaxDeferredExpenseResearchExpenditures	9800000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2392000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6482000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	731000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	322000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2420000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	413000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8884000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4769000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3331000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2421000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1919000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	171000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8591000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2214000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4646000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11420000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3797000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4846000	usd
CY2023	cpsi	Effective Income Tax Rate Reconciliation Provision To Return Adjustments EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustments	999000	usd
CY2022	cpsi	Effective Income Tax Rate Reconciliation Provision To Return Adjustments EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustments	539000	usd
CY2021	cpsi	Effective Income Tax Rate Reconciliation Provision To Return Adjustments EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustments	-117000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2157000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	428000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	509000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2481000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1254000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1274000	usd
CY2023	cpsi	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	0	usd
CY2022	cpsi	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	-406000	usd
CY2021	cpsi	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	7542000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	65000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-112000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-74000	usd
CY2023	cpsi	Effective Income Tax Reconciliation Nondeductible Expense Section162m Limitation EffectiveIncomeTaxReconciliationNondeductibleExpenseSection162mLimitation	15000	usd
CY2022	cpsi	Effective Income Tax Reconciliation Nondeductible Expense Section162m Limitation EffectiveIncomeTaxReconciliationNondeductibleExpenseSection162mLimitation	306000	usd
CY2021	cpsi	Effective Income Tax Reconciliation Nondeductible Expense Section162m Limitation EffectiveIncomeTaxReconciliationNondeductibleExpenseSection162mLimitation	510000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	844000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-6000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	12000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8591000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2214000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4646000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.16
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.12
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.20
CY2022	cpsi	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	-0.022
CY2022	cpsi	Effective Income Tax Rate Reconciliation Provision To Return Adjustments Percent EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsPercent	-0.035
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	600000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	805771	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3271000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5173000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5457000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	687000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1086000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1146000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	2584000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	4087000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	4311000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	6300000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2020Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	49789	shares
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	16500000	usd
CY2019	cpsi	Percentage Of Acute Care Ehr Installations Performed In A Saa S Model PercentageOfAcuteCareEHRInstallationsPerformedInASaaSModel	0.49
CY2018	cpsi	Percentage Of Acute Care Ehr Installations Performed In A Saa S Model PercentageOfAcuteCareEHRInstallationsPerformedInASaaSModel	0.12
CY2021	cpsi	Percentage Of Acute Care Ehr Installations Performed In A Saa S Model PercentageOfAcuteCareEHRInstallationsPerformedInASaaSModel	0.63
CY2022	cpsi	Percentage Of Acute Care Ehr Installations Performed In A Saa S Model PercentageOfAcuteCareEHRInstallationsPerformedInASaaSModel	1
CY2023	cpsi	Percentage Of Acute Care Ehr Installations Performed In A Saa S Model PercentageOfAcuteCareEHRInstallationsPerformedInASaaSModel	1
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	549000	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-133000	usd
CY2023	cpsi	Financing Receivable Allowance For Credit Loss Charge Off FinancingReceivableAllowanceForCreditLossChargeOff	0	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	416000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	722000	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-211000	usd
CY2022	cpsi	Financing Receivable Allowance For Credit Loss Charge Off FinancingReceivableAllowanceForCreditLossChargeOff	38000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	549000	usd
CY2023Q4	cpsi	Financing Receivable Credit Quality Loans With Contractual Maturities Of One Year Or Less FinancingReceivableCreditQualityLoansWithContractualMaturitiesOfOneYearOrLess	788000	usd
CY2022Q4	cpsi	Financing Receivable Credit Quality Loans With Contractual Maturities Of One Year Or Less FinancingReceivableCreditQualityLoansWithContractualMaturitiesOfOneYearOrLess	330000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	416000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	549000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	5223000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	7786000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	186690000	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	17720000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	101116000	usd
CY2023Q4	cpsi	Finite Lived Intangible Assets Accumulated Impairment FiniteLivedIntangibleAssetsAccumulatedImpairment	2342000	usd
CY2023	cpsi	Finite Lived Intangible Assets Written Off Related To Sale Of Business Unit FiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit	11739000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89213000	usd
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P6Y
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	162490000	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	24200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	84690000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	102000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12506000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	12191000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11516000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	10496000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10203000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	32301000	usd
CY2023Q4	cpsi	Finite Lived Intangible Assets Net Including Disposal Group Including Discontinued Operation FiniteLivedIntangibleAssetsNetIncludingDisposalGroupIncludingDiscontinuedOperation	89213000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	177713000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	20540000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	198253000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	17263000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35913000	usd
CY2023	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	7694000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	171909000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1187000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1546000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	198411000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	139529000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3141000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3141000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	195270000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	136388000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5192000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1804000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3074000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4878000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1804000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1063000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1025000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	706000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	462000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	231000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5291000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4878000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1800000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2200000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1800000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1800000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2200000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1800000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	339435000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	326648000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	280629000	usd
CY2023	cpsi	Adjusted Income Loss From Before Interest Taxes Depreciation And Amortization AdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortization	47576000	usd
CY2022	cpsi	Adjusted Income Loss From Before Interest Taxes Depreciation And Amortization AdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortization	55899000	usd
CY2021	cpsi	Adjusted Income Loss From Before Interest Taxes Depreciation And Amortization AdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortization	52677000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45789000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15867000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	18430000	usd
CY2023	cpsi	Contract With Customer Liability And Acquisition Related Adjustments ContractWithCustomerLiabilityAndAcquisitionRelatedAdjustments	0	usd
CY2022	cpsi	Contract With Customer Liability And Acquisition Related Adjustments ContractWithCustomerLiabilityAndAcquisitionRelatedAdjustments	-109000	usd
CY2021	cpsi	Contract With Customer Liability And Acquisition Related Adjustments ContractWithCustomerLiabilityAndAcquisitionRelatedAdjustments	-747000	usd
CY2023	us-gaap	Depreciation Depreciation	1946000	usd
CY2022	us-gaap	Depreciation Depreciation	2443000	usd
CY2021	us-gaap	Depreciation Depreciation	2156000	usd
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	8096000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	3484000	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	931000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16426000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17403000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13786000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3271000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5173000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5457000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	22186000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	4504000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	4892000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11776000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5267000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1632000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35913000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2342000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-565000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8591000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2214000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4646000	usd
CY2023	cpsi	Adjusted Income Loss From Before Interest Taxes Depreciation And Amortization AdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortization	47576000	usd
CY2022	cpsi	Adjusted Income Loss From Before Interest Taxes Depreciation And Amortization AdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortization	55899000	usd
CY2021	cpsi	Adjusted Income Loss From Before Interest Taxes Depreciation And Amortization AdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortization	52677000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001169445-24-000017-index-headers.html	Edgar Link	pending
0001169445-24-000017-index.html	Edgar Link	pending
0001169445-24-000017.txt	Edgar Link	pending
0001169445-24-000017-xbrl.zip	Edgar Link	pending
a2023q4exhibit105.htm	Edgar Link	pending
a2023q4exhibit106.htm	Edgar Link	pending
a2023q4exhibit107.htm	Edgar Link	pending
a2023q4exhibit108.htm	Edgar Link	pending
a2023q4exhibit109.htm	Edgar Link	pending
a2023q4exhibit211.htm	Edgar Link	pending
a2023q4exhibit231.htm	Edgar Link	pending
a2023q4exhibit311.htm	Edgar Link	pending
a2023q4exhibit312.htm	Edgar Link	pending
a2023q4exhibit321.htm	Edgar Link	pending
cpsi-20231231.htm	Edgar Link	pending
cpsi-20231231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
cpsi-20231231_def.xml	Edgar Link	unprocessable
cpsi-20231231_lab.xml	Edgar Link	unprocessable
cpsi-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cpsi-20231231_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpsi-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TBRG
TruBridge Inc Stock $tbrg

2024 Q1 Form 10-K Financial Statement

#000116944524000017 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TBRG TruBridge Inc Stock $tbrg

2024 Q1 Form 10-K Financial Statement

#000116944524000017 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TBRG
TruBridge Inc Stock $tbrg